Prognostic value of B7-H3 expression in patients with solid tumors: a meta-analysis

SUPPLEMENTARY MATERIALS
Supplementary Table 1: Newcastle-Ottawa Scale (NOS) for quality assessment in meta-analysis Selection 1) Representativeness of the exposed cohort a) truly representative of the average (describe) in the community b) somewhat representative of the average in the community c) selected group of users (e.g., nurses, volunteers) d) no description of the derivation of the cohort 2) Selection of the non-exposed cohort a) drawn from the same community as the exposed cohort b) drawn from a different source c) no description of the derivation of the non-exposed cohort 3) Ascertainment of exposure a) secure record (e.g., surgical records) b) structured interview c) written self-report d) no description 4) Demonstration that outcome of interest was not present at start of study a) yes b) no Comparability 1) Comparability of cohorts based on the design or analysis a) study controls for (select the most important factor) b) study controls for any additional factor(This criterion could be modified to indicate specific control for a second important factor.) Outcome 1) Assessment of outcome a) independent blind assessment b) record linkage c) self-report d) no description 2) Follow-up was long enough for outcomes to occur a) yes (select an adequate follow-up period for the outcome of interest) b) no 3) Adequacy of follow-up of cohorts a) complete follow-up -all subjects accounted for b) subjects lost to follow-up unlikely to introduce bias -small number lost ->75% (select an adequate %) or a description of those lost c) follow-up rate < 25% (select an adequate %) and no description of those lost d) no A study can be awarded a maximum of one star for each numbered item within the Selection and Outcome categories. A maximum of two stars can be given for Comparability. 
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